Physician profile
Christopher S Carter
NPI 1295047280
$41,901.49
in general payments reported to CMS, 2019-2025
17 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $17K · 2021: $23K · 2022: $187 · 2023: $139 · 2024: $264 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $40,122.33 | 2019-2023 | Krystexxa |
| Pacira Therapeutics, INC. | $428.15 | 2019-2020 | |
| Bioventus LLC | $402.60 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Zyla Life Sciences, INC. | $213.79 | 2019-2020 | |
| Metuchen Pharmaceuticals | $130.44 | 2020 | |
| Depuy Synthes Sales INC. | $113.87 | 2023-2024 | Monovisc, Truespan Orthocord, Dynacord |
| Novo Nordisk INC | $112.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $87.88 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $69.74 | 2019-2020 | |
| Djo, LLC | $67.70 | 2021-2023 | Aircast, Donjoy |
| Pacira Pharmaceuticals Incorporated | $38.52 | 2023-2024 | Iovera, Exparel, Zilretta |
| Abbott Laboratories | $34.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.70 | 2025 | |
| Glaxosmithkline, LLC. | $16.09 | 2025 | Arexvy, Shingrix |
| Boston Scientific Corporation | $15.97 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $15.31 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.